"10.1371_journal.pone.0084350","plos one","2014-01-06T00:00:00Z","Saud N Al Sifri; Wael Almahmeed; Sami Azar; Osama Okkeh; Peter Bramlage; Claus Jünger; Islam Halawa; Baishali Ambegaonkar; Sameh Wajih; Philippe Brudi","Endocrinology Department, Al Hada Military Hospitals, Taif, Saudi Arabia; Institute of Cardiac Sciences, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates; American University of Beirut Medical Center, Beirut, Lebanon; Istishari Hospital, Amman, Jordan; Institut für Pharmakologie und präventive Medizin, Mahlow, Germany; Institut für Herzinfarktforschung, Ludwigshafen, Germany; University Medical Center, Johannes Gutenberg University, Mainz, Germany; Medical Department, MSD Saudi Arabia, Riyadh, Saudi Arabia; Merck & Co., Inc., Whitehouse Station, New Jersey, United States of America; Medical Department, MSD United Arab Emirates, Abu Dhabi, United Arab Emirates","Analyzed the data: CJ P. Bramlage. Contributed to study concept and design: BA P. Brudi IH CJ SW. Contributed to data acquisition and interpretation of the study:  SAS WA SA OO. Drafted the manuscript: P. Bramlage. Revised the article for important intellectual content:  SAS WA SA OO P. Bramlage CJ IH BA SW P. Brudi. Read and approved the final manuscript to be published: SAS WA SA OO P. Bramlage CJ IH BA SW P. Brudi.","Saud Al Sifri (SAS), Wael Almahmeed (WAM), Sami T. Azar (STA), and Osama Okkeh (OO) are board members and consultants, Peter Bramlage (PBra) and Claus Jünger (CJ) are consultants for Merck & Co Ltd. Baishali Ambegaonkar (BA), Philippe Brudi (PBru), and Sameh Wajih (SW) are employees of Merck & Co Ltd., whose company funded this study. Islam Halawa (IH) has been an employee of Merck & Co Ltd. at the time of the conduct of the study. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Saud N Al Sifri","SNAS",10,TRUE,NA,NA,2,NA,TRUE,FALSE,FALSE,0,NA,FALSE
